MS

Michael John Scott Saunders

AB Argenx Bvba: 3 patents #2 of 23Top 9%
AN Ablynx N.V.: 1 patents #9 of 48Top 20%
LR Ludwig Institute For Cancer Research: 1 patents #16 of 42Top 40%
UL Université Catholique De Louvain: 1 patents #12 of 35Top 35%
Merck: 1 patents #285 of 959Top 30%
📍 Brussels, BE: #5 of 153 inventorsTop 4%
Overall (2020): #32,911 of 565,922Top 6%
5
Patents 2020

Issued Patents 2020

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
10844123 Amino acid sequences that modulate the interaction between cells of the immune system Guy Hermans, Peter Verheesen, Edward Dolk, Hendricus Renerus Jacobus Mattheus Hoogenboom, Hans De Haard +1 more 2020-11-24
10829552 Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same Heidi Rommelaere, Joost Alexander Kolkman, Ann Union, Yolande Chvatchko, Amanda Proudfoot +4 more 2020-11-10
10696741 Anti-IL-22R antibodies Christophe Blanchetot, Birgitte Ursø, Tine Skak-Nielsen, Malene Bertelsen, Sebastian Van Der Woning +1 more 2020-06-30
10676535 Anti c-Met antibodies Anna Hultberg, Johannes Joseph Wilhelmus De Haard, Els Festjens, Natalie De Jonge, Paolo Michieli +2 more 2020-06-09
10604579 Antibody against a complex between human GARP and latent TGF-β Sophie Lucas, Pierre Coulie, Julia Cuende Villasur, Laure Dumoutier, Jean-Christophe Renauld +3 more 2020-03-31